RT Journal Article
SR Electronic
T1 Correction to “Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro CYP Induction Studies Including Impact on Drug Interaction Risk Assessment”
JF Drug Metabolism and Disposition
JO Drug Metab Dispos
FD American Society for Pharmacology and Experimental Therapeutics
SP 344
OP 344
DO 10.1124/dmd.120.000055err
VO 49
IS 4
YR 2021
UL http://dmd.aspetjournals.org/content/49/4/344.abstract
AB